Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study.

Autor: Hahn EE; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. Erin.E.Hahn@kp.org.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA. Erin.E.Hahn@kp.org., Munoz-Plaza CE; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Jensen CD; Kaiser Permanente Division of Research, Oakland, CA, USA., Ghai NR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Pak K; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Amundsen BI; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Contreras R; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Cannizzaro N; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Chubak J; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA., Green BB; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA., Skinner CS; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Halm EA; Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Schottinger JE; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA., Levin TR; Kaiser Permanente Division of Research, Oakland, CA, USA.; Kaiser Permanente Medical Center, Walnut Creek, CA, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2024 Dec; Vol. 39 (16), pp. 3205-3216. Date of Electronic Publication: 2024 May 21.

Use of cancer-directed therapy at the end of life among adolescents and young adults.

Autor: Mack JW; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cernik C; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xu L; MedHealth Statistical Consulting Inc, Solon, OH, USA., Laurent CA; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Fisher L; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cannizzaro N; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Munneke J; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Cooper RM; Department of Pediatric Oncology, Kaiser Permanente Southern California, Pasadena, CA, USA., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA., Schwartz CM; Division of Medical Oncology, Department of Medicine, Kaiser Permanente Northern California, Oakland, CA, USA., Casperson M; Cactus Cancer Society (cactuscancer.org, MC), Oakland, CA, USA., Altschuler A; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Wiener L; Psychosocial Support and Research Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Kushi LH; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Uno H; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jul 01; Vol. 116 (7), pp. 1080-1086.

Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials.

Autor: Christine CW; Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Auinger P; Department of Neurology, Center for Health and Technology, University of Rochester, Rochester, NY, USA., Forti EAR; Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA, USA., Tat L; Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA, USA., Cannizzaro N; Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA, USA., Mustafa A; Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA, USA., Iyer JM; Departments of Molecular and Cellular Biology and Statistics, Harvard University, Cambridge, MA, USA., Oakes D; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA., Green R; Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA, USA.

Publikováno v: Journal of Parkinson's disease [J Parkinsons Dis] 2024; Vol. 14 (6), pp. 1243-1255.

Discussions About Goals of Care and Advance Care Planning Among Adolescents and Young Adults With Cancer Approaching the End of Life.

Autor: Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Cernik C; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Uno H; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Xu L; MedHealth Statistical Consulting Inc, Solon, OH., Laurent CA; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Cannizzaro N; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA., Munneke J; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Cooper RM; Department of Pediatric Oncology, Kaiser Permanente Southern California, Pasadena, CA., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Schwartz CM; Department of Medical Oncology, Kaiser Permanente Northern California, Oakland, CA., Casperson M; Cactus Cancer Society, Oakland, CA., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, MD., Kushi L; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Oct 20; Vol. 41 (30), pp. 4739-4746. Date of Electronic Publication: 2023 Aug 25.

Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.

Autor: Ferlazzo GM; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy.; Aptuit (Verona) S.r.l., an Evotec Company, Campus Levi-Montalcini, 37135, Verona, Italy., Gambetta AM; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy.; Department of Biology, University of Padova, Via U. Bassi 58B, 35131, Padua, Italy., Amato S; Department of Biology, University of Padova, Via U. Bassi 58B, 35131, Padua, Italy.; Department of Neuroscience, University of Padova, Via Belzoni, 160, 35131, Padua, Italy., Cannizzaro N; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy., Angiolillo S; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy., Arboit M; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy., Diamante L; Department of Biology, University of Padova, Via U. Bassi 58B, 35131, Padua, Italy., Carbognin E; Department of Biology, University of Padova, Via U. Bassi 58B, 35131, Padua, Italy., Romani P; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy., La Torre F; Department of Biology, University of Padova, Via U. Bassi 58B, 35131, Padua, Italy., Galimberti E; Max Perutz Laboratories Vienna, University of Vienna, Vienna Biocenter, Dr Bohr Gasse 9, 1030, Vienna, Austria., Pflug F; Max Perutz Laboratories Vienna, University of Vienna, Vienna Biocenter, Dr Bohr Gasse 9, 1030, Vienna, Austria., Luoni M; Division of Neuroscience, San Raffaele Scientific Institute, 20132, Milan, Italy., Giannelli S; Division of Neuroscience, San Raffaele Scientific Institute, 20132, Milan, Italy., Pepe G; IRCCS Neuromed, 86077, Pozzilli, Italy., Capocci L; IRCCS Neuromed, 86077, Pozzilli, Italy., Di Pardo A; IRCCS Neuromed, 86077, Pozzilli, Italy., Vanzani P; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy., Zennaro L; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy., Broccoli V; Division of Neuroscience, San Raffaele Scientific Institute, 20132, Milan, Italy.; CNR Institute of Neuroscience, 20854, Vedrano al Lambro, Italy., Leeb M; Max Perutz Laboratories Vienna, University of Vienna, Vienna Biocenter, Dr Bohr Gasse 9, 1030, Vienna, Austria., Moro E; Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy., Maglione V; IRCCS Neuromed, 86077, Pozzilli, Italy., Martello G; Department of Biology, University of Padova, Via U. Bassi 58B, 35131, Padua, Italy. graziano.martello@unipd.it.

Publikováno v: Nature communications [Nat Commun] 2023 Jul 05; Vol. 14 (1), pp. 3962. Date of Electronic Publication: 2023 Jul 05.